反応式
[N:1]1([N:7]2[NH:11][CH:10]=[C:9]([C:12]3[N:13]([CH3:20])[C:14]([N+:17]([O-:19])=[O:18])=[CH:15][N:16]=3)[S:8]2)[CH2:6][CH2:5]C[CH2:3][CH2:2]1.[CH3:21][N:22]1CCNCC1.N1CCCCC1>>[CH3:21][N:22]1[CH2:5][CH2:6][N:1]([N:7]2[NH:11][CH:10]=[C:9]([C:12]3[N:13]([CH3:20])[C:14]([N+:17]([O-:19])=[O:18])=[CH:15][N:16]=3)[S:8]2)[CH2:2][CH2:3]1参加物
4
実験手順
The preparation of the above compound is carried out in the manner described for the 2-piperidino derivative (Example 28), an equivalent of 1-methylpiperazine replacing the piperidine. The crude product is purified by recrystallization from 2-methoxyethanol and melts at 242°-244° C.
後処理
- customThe preparation of the above compound
- customThe crude product is purified by recrystallization from 2-methoxyethanol and melts at 242°-244° C.
出典と根拠
- ORDレコード
- ord-ddc0afdf3c1241b3bf665258ac784fa3
- 出典データセット
- uspto-grants-1976_11
- 特許番号
- US03991200
関連ノート
読み込み中…